Utility Therapeutics
acquired by Alembic Pharmaceuticals2 known investors
Obtained U.S. FDA approval for pivmecillinam for the treatment of urinary tract infections; acquired by Alembic Pharmaceuticals in July 2025.
Investors · 2
Frequently asked questions
- What does Utility Therapeutics do?
- Obtained U.S. FDA approval for pivmecillinam for the treatment of urinary tract infections; acquired by Alembic Pharmaceuticals in July 2025.
- Who are Utility Therapeutics's investors?
- Utility Therapeutics's investors include 3B Future Health Fund, AMR Action Fund.
- Who acquired Utility Therapeutics?
- Utility Therapeutics was acquired by Alembic Pharmaceuticals.